65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details

臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03080480 (ClinicalTrials.gov)	September 1, 2017	27/2/2017	Pioglitazone Therapy for Chronic Granulomatous Disease	Efficacy and Safety of PioglitazoneTherapy for Chronic Granulomatous Disease Patients With Severe In ...	Chronic Granulomatous Disease	Drug: Pioglitazone	Children's Hospital of Fudan University	NULL	Terminated	1 Month	18 Years	All	3	Phase 1/Phase 2	China
2	NCT02733679 (ClinicalTrials.gov)	September 29, 2016	31/3/2016	Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone	Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone	Ataxia-Telangiectasia	Drug: Metformin;Drug: Pioglitazone	NHS Tayside	University of Dundee	Completed	18 Years	30 Years	All	27	Phase 4	United Kingdom

First Previous1Next Last